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Question
In Behçet’s disease (BD), vasculitis involving blood vessels
of nearly all sizes and types may underlie the diverse tissue
and organ involvement. Loss of function mutations in the
CECR1 gene (encoding adenosine deaminase 2) have
recently been shown to cause a recessive genetic disease,
deficiency of adenine deaminase 2 (DADA2). Patients with
DADA2 exhibit systemic vasculopathy characterized by
intermittent fevers, skin rash, and neurovascular manifes-
tations along with other features that can lead to a diagno-
sis of polyarteritis nodosa. Patients homozygous for the
CECR1 p.Gly47Arg mutation are reported in two non-
consanguineous Turkish families and this mutation is
found at low frequency in the Turkish population. We
therefore attempted to determine whether some BD cases
may be explained by adenosine deaminase 2 deficiency
and whether this mutation contributes to BD risk in
patients of Turkish ancestry.
Methods
Turkish BD patients (n = 1,609) and controls (n = 1,519)
were genotyped for p.Gly47Arg mutations in the CECR1
gene using a Sequenom assay. The assay interrogated two
mutant alleles of the first nucleotide of the Gly47 codon
that both encode the glycine to arginine missense change.
Results
We found p.Gly47Arg mutations in 4 BD patients and
3 healthy controls. No individuals (neither cases or con-
trols) carried two mutant alleles. The carrier frequency for
p.Gly47Arg mutations was 0.002 in cases and in controls.
Conclusions
These data show that the carrier rate of CECR1
p.Gly47Arg mutations is very low in Turkish Behcet’s
patients and not different from controls, suggesting no
contribution to Behcet’s disease.
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